Prelude Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Prelude Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Prelude Therapeutics Inc
Rating: 1.95475
Author: Trendlyne DVM scores

about

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes ...

2.02 -0.19 (-8.60%)

52.13% Fall from 52W High

213.8K

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

17.0 / 100

Technically Moderately Bullish

61.2 / 100

1Yr Price target upside is 98%

3 analysts

Prelude Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prelude Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes ...

52.13% Fall from 52W High

SWOT Analysis

Prelude Therapeutics Inc Live Price Chart